Back to Research Hub
Royalty Pharma plc
RPRX
$55.63+0.77 (+1.40%)
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies.
StreetsValue research for Royalty Pharma plc (RPRX)
Members get the full report for Royalty Pharma plc: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.